QSI vs. TRNS, CTKB, LAB, EYPT, AEHR, SENS, ALNT, QTRX, NAUT, and KEQU
Should you be buying Quantum-Si stock or one of its competitors? The main competitors of Quantum-Si include Transcat (TRNS), Cytek Biosciences (CTKB), Standard BioTools (LAB), EyePoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Senseonics (SENS), Allient (ALNT), Quanterix (QTRX), Nautilus Biotechnology (NAUT), and Kewaunee Scientific (KEQU). These companies are all part of the "measuring and control equipment" industry.
Quantum-Si vs.
Quantum-Si (NASDAQ:QSI) and Transcat (NASDAQ:TRNS) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, community ranking, analyst recommendations, profitability, dividends, valuation and earnings.
Transcat has a net margin of 6.63% compared to Quantum-Si's net margin of -3,968.84%. Transcat's return on equity of 7.36% beat Quantum-Si's return on equity.
Transcat received 203 more outperform votes than Quantum-Si when rated by MarketBeat users. However, 70.00% of users gave Quantum-Si an outperform vote while only 66.88% of users gave Transcat an outperform vote.
Transcat has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.
In the previous week, Quantum-Si had 14 more articles in the media than Transcat. MarketBeat recorded 18 mentions for Quantum-Si and 4 mentions for Transcat. Quantum-Si's average media sentiment score of 0.38 beat Transcat's score of 0.00 indicating that Quantum-Si is being referred to more favorably in the media.
Quantum-Si has a beta of 2.74, meaning that its stock price is 174% more volatile than the S&P 500. Comparatively, Transcat has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500.
Quantum-Si currently has a consensus price target of $3.25, indicating a potential upside of 45.09%. Transcat has a consensus price target of $130.25, indicating a potential upside of 29.81%. Given Quantum-Si's higher probable upside, equities analysts clearly believe Quantum-Si is more favorable than Transcat.
39.9% of Quantum-Si shares are held by institutional investors. Comparatively, 98.3% of Transcat shares are held by institutional investors. 30.0% of Quantum-Si shares are held by company insiders. Comparatively, 2.3% of Transcat shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
Transcat beats Quantum-Si on 11 of the 18 factors compared between the two stocks.
Get Quantum-Si News Delivered to You Automatically
Sign up to receive the latest news and ratings for QSI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quantum-Si Competitors List
Related Companies and Tools
This page (NASDAQ:QSI) was last updated on 1/21/2025 by MarketBeat.com Staff
